Regulatory

Health Canada approves Biocon’s two denosumab biosimilars

Pharmaceutical Technology

Biocon has received a Notice of Compliance from Health Canada for Bosaya and Vevzuo, both biosimilars referencing Prolia and Xgeva, respectively.

Regulatory Read full story

pharminent April 22, 2026 (Last updated: April 22, 2026)

Pharmaceutical Technology

Biocon has received a Notice of Compliance from Health Canada for Bosaya and Vevzuo, both biosimilars referencing Prolia and Xgeva, respectively.

Regulatory Read full story